EQUITY RESEARCH MEMO

Scanlan International

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

Scanlan International is a century-old, family-owned manufacturer of premium surgical instruments headquartered in Saint Paul, Minnesota. The company specializes in reusable and single-use instruments for open and minimally invasive surgery, with a strong emphasis on cardiovascular, thoracic, and general surgical specialties. Its core value proposition lies in high-quality, precision instrumentation developed in close collaboration with surgeons. As a private entity with no disclosed financials, Scanlan is not subject to public market pressures but benefits from deep customer loyalty and a reputation for craftsmanship. However, its small scale and limited product portfolio relative to larger competitors may constrain growth.

Upcoming Catalysts (preview)

  • Q3 2026Launch of Next-Generation Minimally Invasive Surgical Instruments70% success
  • Q1 2027FDA Clearance for New Cardiovascular-Specific Device60% success
  • Q4 2026Expansion into Asian Surgical Markets via Distribution Partnerships50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)